866-997-4948(US-Canada Toll Free)

Global Anti-Obesity Therapeutics Sales Market Report 2018

Published By :

QYResearch

Published Date : Aug 2018

Category :

Pharmaceutical

No. of Pages : 111 Pages

This report studies the global Anti-Obesity Therapeutics market status and forecast, categorizes the global Anti-Obesity Therapeutics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.
Geographically, North America captures the largest market share on account of increasing obese population. As per the historical trends, more than one-third of the U.S. population is obese. However, Asia Pacific is anticipated to grow at the fastest rate due to increasing demand for the drugs and awareness about the risk associated with obesity. According to WHO, 13.0% of the population were obese in 2014. In developing countries the rate of childhood obesity is increasing and has been 30.0% higher than that of developed countries.
The global Anti-Obesity Therapeutics market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
Bristol-Myers Squibb
Eisai Company
FlaxoSithKline plc.
Novo Nordisk
Alizyme
BoehringerIngelheim GmbH
Pfizer
Takeda Pharmaceutical
Rhythm Pharmaceuticals
Shionogi USA
Vivus
Zafgen
Norgine Pharmaceuticals Ltd.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Centrally Acting Anti-obesity Drugs
Peripherally Acting Anti-obesity Drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital Use
Clinic Use
Household
Other

The study objectives of this report are:
To analyze and study the global Anti-Obesity Therapeutics sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Anti-Obesity Therapeutics players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Anti-Obesity Therapeutics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Anti-Obesity Therapeutics Manufacturers
Anti-Obesity Therapeutics Distributors/Traders/Wholesalers
Anti-Obesity Therapeutics Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Anti-Obesity Therapeutics market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents

Global Anti-Obesity Therapeutics Sales Market Report 2018
1 Anti-Obesity Therapeutics Market Overview
1.1 Product Overview and Scope of Anti-Obesity Therapeutics
1.2 Classification of Anti-Obesity Therapeutics by Product Category
1.2.1 Global Anti-Obesity Therapeutics Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Anti-Obesity Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Centrally Acting Anti-obesity Drugs
1.2.4 Peripherally Acting Anti-obesity Drugs
1.3 Global Anti-Obesity Therapeutics Market by Application/End Users
1.3.1 Global Anti-Obesity Therapeutics Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Hospital Use
1.3.2 Clinic Use
1.3.3 Household
1.3.4 Other
1.4 Global Anti-Obesity Therapeutics Market by Region
1.4.1 Global Anti-Obesity Therapeutics Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Anti-Obesity Therapeutics Status and Prospect (2013-2025)
1.4.3 Europe Anti-Obesity Therapeutics Status and Prospect (2013-2025)
1.4.4 China Anti-Obesity Therapeutics Status and Prospect (2013-2025)
1.4.5 Japan Anti-Obesity Therapeutics Status and Prospect (2013-2025)
1.4.6 Southeast Asia Anti-Obesity Therapeutics Status and Prospect (2013-2025)
1.4.7 India Anti-Obesity Therapeutics Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Anti-Obesity Therapeutics (2013-2025)
1.5.1 Global Anti-Obesity Therapeutics Sales and Growth Rate (2013-2025)
1.5.2 Global Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2025)

2 Global Anti-Obesity Therapeutics Competition by Players/Suppliers, Type and Application
2.1 Global Anti-Obesity Therapeutics Market Competition by Players/Suppliers
2.1.1 Global Anti-Obesity Therapeutics Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Anti-Obesity Therapeutics Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Anti-Obesity Therapeutics (Volume and Value) by Type
2.2.1 Global Anti-Obesity Therapeutics Sales and Market Share by Type (2013-2018)
2.2.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Type (2013-2018)
2.3 Global Anti-Obesity Therapeutics (Volume and Value) by Region
2.3.1 Global Anti-Obesity Therapeutics Sales and Market Share by Region (2013-2018)
2.3.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Region (2013-2018)
2.4 Global Anti-Obesity Therapeutics (Volume) by Application

3 United States Anti-Obesity Therapeutics (Volume, Value and Sales Price)
3.1 United States Anti-Obesity Therapeutics Sales and Value (2013-2018)
3.1.1 United States Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
3.1.2 United States Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
3.1.3 United States Anti-Obesity Therapeutics Sales Price Trend (2013-2018)
3.2 United States Anti-Obesity Therapeutics Sales Volume and Market Share by Players (2013-2018)
3.3 United States Anti-Obesity Therapeutics Sales Volume and Market Share by Type (2013-2018)
3.4 United States Anti-Obesity Therapeutics Sales Volume and Market Share by Application (2013-2018)

4 Europe Anti-Obesity Therapeutics (Volume, Value and Sales Price)
4.1 Europe Anti-Obesity Therapeutics Sales and Value (2013-2018)
4.1.1 Europe Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
4.1.2 Europe Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
4.1.3 Europe Anti-Obesity Therapeutics Sales Price Trend (2013-2018)
4.2 Europe Anti-Obesity Therapeutics Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Anti-Obesity Therapeutics Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Anti-Obesity Therapeutics Sales Volume and Market Share by Application (2013-2018)

5 China Anti-Obesity Therapeutics (Volume, Value and Sales Price)
5.1 China Anti-Obesity Therapeutics Sales and Value (2013-2018)
5.1.1 China Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
5.1.2 China Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
5.1.3 China Anti-Obesity Therapeutics Sales Price Trend (2013-2018)
5.2 China Anti-Obesity Therapeutics Sales Volume and Market Share by Players (2013-2018)
5.3 China Anti-Obesity Therapeutics Sales Volume and Market Share by Type (2013-2018)
5.4 China Anti-Obesity Therapeutics Sales Volume and Market Share by Application (2013-2018)

6 Japan Anti-Obesity Therapeutics (Volume, Value and Sales Price)
6.1 Japan Anti-Obesity Therapeutics Sales and Value (2013-2018)
6.1.1 Japan Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
6.1.2 Japan Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
6.1.3 Japan Anti-Obesity Therapeutics Sales Price Trend (2013-2018)
6.2 Japan Anti-Obesity Therapeutics Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Anti-Obesity Therapeutics Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Anti-Obesity Therapeutics Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Anti-Obesity Therapeutics (Volume, Value and Sales Price)
7.1 Southeast Asia Anti-Obesity Therapeutics Sales and Value (2013-2018)
7.1.1 Southeast Asia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Anti-Obesity Therapeutics Sales Price Trend (2013-2018)
7.2 Southeast Asia Anti-Obesity Therapeutics Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Anti-Obesity Therapeutics Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Anti-Obesity Therapeutics Sales Volume and Market Share by Application (2013-2018)

8 India Anti-Obesity Therapeutics (Volume, Value and Sales Price)
8.1 India Anti-Obesity Therapeutics Sales and Value (2013-2018)
8.1.1 India Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)
8.1.2 India Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)
8.1.3 India Anti-Obesity Therapeutics Sales Price Trend (2013-2018)
8.2 India Anti-Obesity Therapeutics Sales Volume and Market Share by Players (2013-2018)
8.3 India Anti-Obesity Therapeutics Sales Volume and Market Share by Type (2013-2018)
8.4 India Anti-Obesity Therapeutics Sales Volume and Market Share by Application (2013-2018)

9 Global Anti-Obesity Therapeutics Players/Suppliers Profiles and Sales Data
9.1 Bristol-Myers Squibb
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Anti-Obesity Therapeutics Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Bristol-Myers Squibb Anti-Obesity Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Eisai Company
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Anti-Obesity Therapeutics Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Eisai Company Anti-Obesity Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 FlaxoSithKline plc.
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Anti-Obesity Therapeutics Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 FlaxoSithKline plc. Anti-Obesity Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Novo Nordisk
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Anti-Obesity Therapeutics Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Novo Nordisk Anti-Obesity Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Alizyme
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Anti-Obesity Therapeutics Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Alizyme Anti-Obesity Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 BoehringerIngelheim GmbH
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Anti-Obesity Therapeutics Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Pfizer
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Anti-Obesity Therapeutics Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Pfizer Anti-Obesity Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Takeda Pharmaceutical
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Anti-Obesity Therapeutics Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Takeda Pharmaceutical Anti-Obesity Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Rhythm Pharmaceuticals
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Anti-Obesity Therapeutics Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Shionogi USA
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Anti-Obesity Therapeutics Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Shionogi USA Anti-Obesity Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Vivus
9.12 Zafgen
9.13 Norgine Pharmaceuticals Ltd.

10 Anti-Obesity Therapeutics Maufacturing Cost Analysis
10.1 Anti-Obesity Therapeutics Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Anti-Obesity Therapeutics
10.3 Manufacturing Process Analysis of Anti-Obesity Therapeutics

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Anti-Obesity Therapeutics Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Anti-Obesity Therapeutics Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Anti-Obesity Therapeutics Market Forecast (2018-2025)
14.1 Global Anti-Obesity Therapeutics Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Anti-Obesity Therapeutics Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Anti-Obesity Therapeutics Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Anti-Obesity Therapeutics Price and Trend Forecast (2018-2025)
14.2 Global Anti-Obesity Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Anti-Obesity Therapeutics Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Anti-Obesity Therapeutics Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Anti-Obesity Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Anti-Obesity Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Anti-Obesity Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Anti-Obesity Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Anti-Obesity Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Anti-Obesity Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Anti-Obesity Therapeutics Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Anti-Obesity Therapeutics Sales Forecast by Type (2018-2025)
14.3.2 Global Anti-Obesity Therapeutics Revenue Forecast by Type (2018-2025)
14.3.3 Global Anti-Obesity Therapeutics Price Forecast by Type (2018-2025)
14.4 Global Anti-Obesity Therapeutics Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Anti-Obesity Therapeutics
Figure Global Anti-Obesity Therapeutics Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Anti-Obesity Therapeutics Sales Volume Market Share by Type (Product Category) in 2017
Figure Centrally Acting Anti-obesity Drugs Product Picture
Figure Peripherally Acting Anti-obesity Drugs Product Picture
Figure Global Anti-Obesity Therapeutics Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Anti-Obesity Therapeutics by Application in 2017
Figure Hospital Use Examples
Table Key Downstream Customer in Hospital Use
Figure Clinic Use Examples
Table Key Downstream Customer in Clinic Use
Figure Household Examples
Table Key Downstream Customer in Household
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Anti-Obesity Therapeutics Market Size (Million USD) by Regions (2013-2025)
Figure United States Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Anti-Obesity Therapeutics Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Anti-Obesity Therapeutics Sales Volume (K Units) (2013-2018)
Table Global Anti-Obesity Therapeutics Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Anti-Obesity Therapeutics Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Anti-Obesity Therapeutics Sales Share by Players/Suppliers
Figure 2017 Anti-Obesity Therapeutics Sales Share by Players/Suppliers
Figure Global Anti-Obesity Therapeutics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Anti-Obesity Therapeutics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Anti-Obesity Therapeutics Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Anti-Obesity Therapeutics Revenue Share by Players
Table 2017 Global Anti-Obesity Therapeutics Revenue Share by Players
Table Global Anti-Obesity Therapeutics Sales (K Units) and Market Share by Type (2013-2018)
Table Global Anti-Obesity Therapeutics Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Anti-Obesity Therapeutics by Type (2013-2018)
Figure Global Anti-Obesity Therapeutics Sales Growth Rate by Type (2013-2018)
Table Global Anti-Obesity Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Anti-Obesity Therapeutics Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Anti-Obesity Therapeutics by Type (2013-2018)
Figure Global Anti-Obesity Therapeutics Revenue Growth Rate by Type (2013-2018)
Table Global Anti-Obesity Therapeutics Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Anti-Obesity Therapeutics Sales Share by Region (2013-2018)
Figure Sales Market Share of Anti-Obesity Therapeutics by Region (2013-2018)
Figure Global Anti-Obesity Therapeutics Sales Growth Rate by Region in 2017
Table Global Anti-Obesity Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Anti-Obesity Therapeutics Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Anti-Obesity Therapeutics by Region (2013-2018)
Figure Global Anti-Obesity Therapeutics Revenue Growth Rate by Region in 2017
Table Global Anti-Obesity Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Anti-Obesity Therapeutics Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Anti-Obesity Therapeutics by Region (2013-2018)
Figure Global Anti-Obesity Therapeutics Revenue Market Share by Region in 2017
Table Global Anti-Obesity Therapeutics Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Anti-Obesity Therapeutics Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Anti-Obesity Therapeutics by Application (2013-2018)
Figure Global Anti-Obesity Therapeutics Sales Market Share by Application (2013-2018)
Figure United States Anti-Obesity Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure United States Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Anti-Obesity Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table United States Anti-Obesity Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table United States Anti-Obesity Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure United States Anti-Obesity Therapeutics Sales Volume Market Share by Players in 2017
Table United States Anti-Obesity Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table United States Anti-Obesity Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure United States Anti-Obesity Therapeutics Sales Volume Market Share by Type in 2017
Table United States Anti-Obesity Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table United States Anti-Obesity Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure United States Anti-Obesity Therapeutics Sales Volume Market Share by Application in 2017
Figure Europe Anti-Obesity Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Anti-Obesity Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Anti-Obesity Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table Europe Anti-Obesity Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure Europe Anti-Obesity Therapeutics Sales Volume Market Share by Players in 2017
Table Europe Anti-Obesity Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table Europe Anti-Obesity Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure Europe Anti-Obesity Therapeutics Sales Volume Market Share by Type in 2017
Table Europe Anti-Obesity Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table Europe Anti-Obesity Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure Europe Anti-Obesity Therapeutics Sales Volume Market Share by Application in 2017
Figure China Anti-Obesity Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure China Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Anti-Obesity Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table China Anti-Obesity Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table China Anti-Obesity Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure China Anti-Obesity Therapeutics Sales Volume Market Share by Players in 2017
Table China Anti-Obesity Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table China Anti-Obesity Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure China Anti-Obesity Therapeutics Sales Volume Market Share by Type in 2017
Table China Anti-Obesity Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table China Anti-Obesity Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure China Anti-Obesity Therapeutics Sales Volume Market Share by Application in 2017
Figure Japan Anti-Obesity Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Anti-Obesity Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Anti-Obesity Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table Japan Anti-Obesity Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure Japan Anti-Obesity Therapeutics Sales Volume Market Share by Players in 2017
Table Japan Anti-Obesity Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table Japan Anti-Obesity Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure Japan Anti-Obesity Therapeutics Sales Volume Market Share by Type in 2017
Table Japan Anti-Obesity Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table Japan Anti-Obesity Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure Japan Anti-Obesity Therapeutics Sales Volume Market Share by Application in 2017
Figure Southeast Asia Anti-Obesity Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Anti-Obesity Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Anti-Obesity Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Anti-Obesity Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Anti-Obesity Therapeutics Sales Volume Market Share by Players in 2017
Table Southeast Asia Anti-Obesity Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Anti-Obesity Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Anti-Obesity Therapeutics Sales Volume Market Share by Type in 2017
Table Southeast Asia Anti-Obesity Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Anti-Obesity Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Anti-Obesity Therapeutics Sales Volume Market Share by Application in 2017
Figure India Anti-Obesity Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure India Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Anti-Obesity Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table India Anti-Obesity Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table India Anti-Obesity Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure India Anti-Obesity Therapeutics Sales Volume Market Share by Players in 2017
Table India Anti-Obesity Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table India Anti-Obesity Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure India Anti-Obesity Therapeutics Sales Volume Market Share by Type in 2017
Table India Anti-Obesity Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table India Anti-Obesity Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure India Anti-Obesity Therapeutics Sales Volume Market Share by Application in 2017
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Anti-Obesity Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Anti-Obesity Therapeutics Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Anti-Obesity Therapeutics Sales Global Market Share (2013-2018)
Figure Bristol-Myers Squibb Anti-Obesity Therapeutics Revenue Global Market Share (2013-2018)
Table Eisai Company Basic Information List
Table Eisai Company Anti-Obesity Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eisai Company Anti-Obesity Therapeutics Sales Growth Rate (2013-2018)
Figure Eisai Company Anti-Obesity Therapeutics Sales Global Market Share (2013-2018)
Figure Eisai Company Anti-Obesity Therapeutics Revenue Global Market Share (2013-2018)
Table FlaxoSithKline plc. Basic Information List
Table FlaxoSithKline plc. Anti-Obesity Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure FlaxoSithKline plc. Anti-Obesity Therapeutics Sales Growth Rate (2013-2018)
Figure FlaxoSithKline plc. Anti-Obesity Therapeutics Sales Global Market Share (2013-2018
Figure FlaxoSithKline plc. Anti-Obesity Therapeutics Revenue Global Market Share (2013-2018)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Anti-Obesity Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novo Nordisk Anti-Obesity Therapeutics Sales Growth Rate (2013-2018)
Figure Novo Nordisk Anti-Obesity Therapeutics Sales Global Market Share (2013-2018)
Figure Novo Nordisk Anti-Obesity Therapeutics Revenue Global Market Share (2013-2018)
Table Alizyme Basic Information List
Table Alizyme Anti-Obesity Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Alizyme Anti-Obesity Therapeutics Sales Growth Rate (2013-2018)
Figure Alizyme Anti-Obesity Therapeutics Sales Global Market Share (2013-2018)
Figure Alizyme Anti-Obesity Therapeutics Revenue Global Market Share (2013-2018)
Table BoehringerIngelheim GmbH Basic Information List
Table BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales Growth Rate (2013-2018)
Figure BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales Global Market Share (2013-2018
Figure BoehringerIngelheim GmbH Anti-Obesity Therapeutics Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Anti-Obesity Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Anti-Obesity Therapeutics Sales Growth Rate (2013-2018)
Figure Pfizer Anti-Obesity Therapeutics Sales Global Market Share (2013-2018)
Figure Pfizer Anti-Obesity Therapeutics Revenue Global Market Share (2013-2018)
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Anti-Obesity Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Takeda Pharmaceutical Anti-Obesity Therapeutics Sales Growth Rate (2013-2018)
Figure Takeda Pharmaceutical Anti-Obesity Therapeutics Sales Global Market Share (2013-2018
Figure Takeda Pharmaceutical Anti-Obesity Therapeutics Revenue Global Market Share (2013-2018)
Table Rhythm Pharmaceuticals Basic Information List
Table Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales Growth Rate (2013-2018)
Figure Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales Global Market Share (2013-2018)
Figure Rhythm Pharmaceuticals Anti-Obesity Therapeutics Revenue Global Market Share (2013-2018)
Table Shionogi USA Basic Information List
Table Shionogi USA Anti-Obesity Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shionogi USA Anti-Obesity Therapeutics Sales Growth Rate (2013-2018)
Figure Shionogi USA Anti-Obesity Therapeutics Sales Global Market Share (2013-2018)
Figure Shionogi USA Anti-Obesity Therapeutics Revenue Global Market Share (2013-2018)
Table Vivus Basic Information List
Table Zafgen Basic Information List
Table Norgine Pharmaceuticals Ltd. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Obesity Therapeutics
Figure Manufacturing Process Analysis of Anti-Obesity Therapeutics
Figure Anti-Obesity Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Anti-Obesity Therapeutics Major Players in 2017
Table Major Buyers of Anti-Obesity Therapeutics
Table Distributors/Traders List
Figure Global Anti-Obesity Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Anti-Obesity Therapeutics Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Anti-Obesity Therapeutics Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Anti-Obesity Therapeutics Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Anti-Obesity Therapeutics Sales Volume Market Share Forecast by Regions in 2025
Table Global Anti-Obesity Therapeutics Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Anti-Obesity Therapeutics Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Anti-Obesity Therapeutics Revenue Market Share Forecast by Regions in 2025
Figure United States Anti-Obesity Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Anti-Obesity Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Anti-Obesity Therapeutics Revenue and Growth Rate Forecast (2018-2025)
Figure China Anti-Obesity Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Anti-Obesity Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Anti-Obesity Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Anti-Obesity Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Anti-Obesity Therapeutics Sales (K Units) Forecast by Type (2018-2025)
Figure Global Anti-Obesity Therapeutics Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Anti-Obesity Therapeutics Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Anti-Obesity Therapeutics Revenue Market Share Forecast by Type (2018-2025)
Table Global Anti-Obesity Therapeutics Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Anti-Obesity Therapeutics Sales (K Units) Forecast by Application (2018-2025)
Figure Global Anti-Obesity Therapeutics Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *